Are patents signals for the IPO market? An EU–US comparison for the software industry D Useche Research Policy 43 (8), 1299-1311, 2014 | 104 | 2014 |
Highly skilled and well connected: Migrant inventors in cross-border M&As D Useche, E Miguelez, F Lissoni Journal of International Business Studies 51, 737-763, 2020 | 51 | 2020 |
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital V Butticè, D Useche Small Business Economics 59 (4), 1519-1540, 2022 | 25* | 2022 |
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms D Useche, S Pommet Small Business Economics 57 (3), 1339-1359, 2021 | 16 | 2021 |
Orphan drug designations as valuable intangible assets for IPO investors in pharma-biotech companies P Gorry, D Useche National Bureau of Economic Research, 2017 | 15 | 2017 |
Relevancia, evolución y tendencias de la supervivencia empresarial. Una revisión de literatura en finanzas P Zuluaga Arango, D Useche Rincón, SP Rojas Berrio Tendencias 24 (1), 252-278, 2023 | 12 | 2023 |
Patenting behaviour and the survival of newly listed European software firms D Useche Industry and Innovation 22 (1), 37-58, 2015 | 11 | 2015 |
Signaling Quality to Bridge the Ethnic and Gender Gap: Evidence for Ethnic Women Entrepreneurs D Useche, V Butticè SSRN Electronic Journal. Available at SSRN: https://ssrn.com/abstract …, 2024 | | 2024 |
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021. P Gorry, D Useche | | 2017 |
Empirical Economic Analysis of Orphan Drug Innovation P Gorry, D Useche, M Zumpe HAL Post-Print, 2016 | | 2016 |
Les droits de la propriété Intellectuelle et les marchés financiers dans la stratégie des firmes du logiciel en Europe et aux Etats-Unis D Useche Université de Bordeaux, 2014 | | 2014 |
Call for Papers-The challenges and opportunities of high-skilled migration V Butticè, D Useche | | |